Lv11
10 积分 2026-05-12 加入
Safety, pharmacokinetics (PK), and cost-effectiveness of upfront genotyping of DPYD in fluoropyrimidine therapy
4小时前
求助中
Cost Evaluation of Irinotecan‐Related Toxicities Associated With the UGT1A1*28 Patient Genotype
22天前
已完结
The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance
22天前
已完结
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
1个月前
已完结
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
1个月前
已完结
Testing for dihydropyrimidine dehydrogenase deficiency in New Zealand to improve the safe use of 5-fluorouracil and capecitabine in cancer patients
1个月前
已关闭
Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer
1个月前
已完结
Economic Evaluation of Pre-emptive Pharmacogenetic Panel Testing versus No Genetic Testing in a Multi-ethnic Asian Population
1个月前
已完结
Cost–Effectiveness Analysis of Personalized Antiplatelet Therapy in Patients with Acute Coronary Syndrome
1个月前
已完结
Cost–Effectiveness Analysis of Personalized Antiplatelet Therapy in Patients with Acute Coronary Syndrome
1个月前
已关闭
皖公网安备34019202002308
